Wedbush Maintains Outperform on Varonis Systems, Raises Price Target to $80

Wedbush analyst Daniel Ives maintains Varonis Systems (NASDAQ:VRNS) with a Outperform and raises the price target from $70 to $80.

byBenzinga Newsdesk

August 3, 2021

1 minute read

Wedbush analyst Daniel Ives maintains Varonis Systems (NASDAQ:VRNS) with a Outperform and raises the price target from $70 to $80.

EF Hutton Maintains Buy on Limbach Holdings, Raises Price Target to $18

By Benzinga Newsdesk

March 10, 8:22 AM

EF Hutton analyst Chip Moore maintains Limbach Holdings (NASDAQ:LMB) with a Buy and raises the price target from $15 to $18.

LMB

– Canadian Solar Signed Two 10-year Power Purchase Agreements with Axpo Italia

By Charles Gross

March 8, 8:10 AM

Canadian Solar Inc. ("Canadian Solar" or the "Company") (NASDAQ: CSIQ) today announced it has signed two 10-year power purchase agreements (PPA) with Axpo Italia for the purchase of 70% of energy produced by two solar power plants under development totaling 84 MWp.

CSIQ

CbdMD Receives $1M Return Of Capital Following Closing Of Adara SPAC Transaction

By Happy Mohamed

February 13, 12:29 PM

cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the closing of the return of its $1 million investment

ADRA

If You Invested $1000 In Boston Scientific 10 Years Ago, Here’s How Much You Would Have Today

By Benzinga Insights

May 27, 12:08 PM

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.68% on an annualized basis producing an average annual return of 21.79%. Currently, Boston Scientific has a market capitalization of $58.91 billion.

BSX

Wedbush Maintains Outperform on Varonis Systems, Raises Price Target to $80

Related Posts

EF Hutton Maintains Buy on Limbach Holdings, Raises Price Target to $18

– Canadian Solar Signed Two 10-year Power Purchase Agreements with Axpo Italia

CbdMD Receives $1M Return Of Capital Following Closing Of Adara SPAC Transaction

If You Invested $1000 In Boston Scientific 10 Years Ago, Here’s How Much You Would Have Today